Hauptinhalt

Bibliografische Daten

Dokument US020070122436A1 (Seiten: 17)

Bibliografische Daten Dokument US020070122436A1 (Seiten: 17)
INID Kriterium Feld Inhalt
54 Titel TI [EN] Nanoparticulate active substance formulations
71/73 Anmelder/Inhaber PA BRATZ MATTHIAS ; GOEDEL WERNER ; KOLTZENBURG SEBASTIAN ; LEHMANN STEPHAN ; MAYER WINFRIED
72 Erfinder IN BRATZ MATTHIAS, DE ; GOEDEL WERNER, DE ; KOLTZENBURG SEBASTIAN, DE ; LEHMANN STEPHAN, DE ; MAYER WINFRIED, DE
22/96 Anmeldedatum AD 19.10.2004
21 Anmeldenummer AN 57692104
Anmeldeland AC US
Veröffentlichungsdatum PUB 31.05.2007
33
31
32
Priorität PRC
PRN
PRD
DE
10351004
30.10.2003
33
31
32
PRC
PRN
PRD
EP
2004011797
19.10.2004
51 IPC-Hauptklasse ICM A01N 25/00 (2006.01)
51 IPC-Nebenklasse ICS
IPC-Zusatzklasse ICA
IPC-Indexklasse ICI
Gemeinsame Patentklassifikation CPC A01N 25/04
A01N 25/10
A01N 25/30
A01N 47/10
A01N 47/24
C08F 220/1804
C08F 220/301
C08F 220/585
MCD-Hauptklasse MCM A01N 25/00 (2006.01)
MCD-Nebenklasse MCS A01N 25/04 (2006.01)
A01N 25/30 (2006.01)
A01N 47/24 (2006.01)
MCD-Zusatzklasse MCA
57 Zusammenfassung AB [EN] The invention relates to nanoparticulate formulations comprising at least one active compound or compound with a special effect and at least one random radical copolymer. The copolymers are formed from monomers carrying sulfonic acid groups and additional olefinically unsaturated compounds. The formulations are dispersible as nanoparticles in an aqueous medium. The invention includes, in addition, processes for the preparation of the solid and liquid formulations, and their use.
56 Entgegengehaltene Patentdokumente/Zitate,
in Recherche ermittelt
CT US000004409358A
US000004512969A
US000004528185A
US000005118528A
US000005133908A
US000005319093A
US000005787686A
US000006458745B1
US000006616946B1
US000006869914B2
US020030118614A1
US020050032903A1
US020050101639A1
US020050165076A1
US020050182219A1
US020060030486A1
56 Entgegengehaltene Patentdokumente/Zitate,
vom Anmelder genannt
CT
56 Entgegengehaltene Nichtpatentliteratur/Zitate,
in Recherche ermittelt
CTNP
56 Entgegengehaltene Nichtpatentliteratur/Zitate,
vom Anmelder genannt
CTNP
Zitierende Dokumente AU002013322338B2
EP000002793574A4
US000007872067B2
US000007927617B2
US000007994227B2
US000008211469B2
US000008541012B2
US000008563471B2
US000008906399B2
US000009185905B2
US000009480250B2
US000009522970B2
US000009579738B2
US000009686979B2
US000009808874B2
US000009815149B2
US000010136637B2
US000010206391B2
US000010455830B2
US000010561733B2
US000010966422B2
US000011344028B2
US000011503825B2
US000011517013B2
US020070225169A1
US020080287593A1
US020080318785A1
US020090227457A1
US020090227460A1
US020090239749A1
US020100048655A1
US020100067690A1
US020110166309A1
US020110237439A1
US020120217289A1
US020130001279A1
US020150051181A1
WO002014049347A1
Sequenzprotokoll
Prüfstoff-IPC ICP A01N 37/02
A01N 37/06